Lisocabtagene maraleucel for R/R LBCL in patients not intended for HSCT: final results of the phase 2 PILOT study
利索卡巴吉内马拉鲁塞用于不适合接受造血干细胞移植的复发/难治性大B细胞淋巴瘤患者:2期试点研究的最终结果
期刊:Blood Advances
影响因子:7.1
doi:10.1182/bloodadvances.2024015262
Sehgal, Alison; Hoda, Daanish; Riedell, Peter A; Ghosh, Nilanjan; Hamadani, Mehdi; Hildebrandt, Gerhard C; Godwin, John E; Reagan, Patrick M; Wagner-Johnston, Nina D; Essell, James; Nath, Rajneesh; Solomon, Scott R; Champion, Rebecca; Licitra, Edward; Fanning, Suzanne; Gupta, Neel K; Chow, Victor A; Yuan, Brenda; Yang, Zhi; Ogasawara, Ken; Thorpe, Jerill; Gordon, Leo I
B细胞
发育与干细胞
淋巴瘤
干细胞
细胞生物学
免疫/内分泌